logo
Focused ultrasound: crossing barriers to treat Alzheimer's disease
US FDA Investigational New Drug approval for first-in-human trial of novel cancer-targeting nanoparticle
Modified mRNA shows potential as gene-delivery method in mouse model
Novel technology that measures and visualizes drug delivery to tumors shown in proof-of-concept study
‘Rising star’ scientist granted Norman Hackerman award for work on nanoparticles
Industry Update: The latest developments in therapeutic delivery
Conference Report: Pharmaceutical Technology, Biopharmaceutics and Drug Delivery
Conference Report: Drug Delivery to the Lungs 21
Meeting Report: Summary of Abbreviated Impactor Measurement Workshop organized by the European Pharmaceutical Aerosol Group
Drug delivery to the brain via the blood–brain barrier: a review of the literature and some recent patent disclosures
Monoclonal antibodies: from benchtop to bedside
Monoclonal antibody dose determination and biodistribution into solid tumors
Quantitative and specific molecular imaging of cancer with labeled engineered monoclonal antibody fragments
Monoclonal antibodies: interspecies scaling with minimal preclinical information
Individualizing therapy of monoclonal antibodies and fusion proteins: emerging potential in the age of personalized medicine
Quality assessment of bioanalytical quantification of monoclonal antibody drugs
Antibody–drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells
Acknowledgements